1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
05/19/2022 05/20/2022 05/23/2022 05/24/2022 05/25/2022 Date
284.9(c) 286(c) 279.1(c) 279.1(c) 269 Last
707 033 675 617 527 269 508 011 409 901 Volume
-1.11% +0.39% -2.41% 0.00% -3.62% Change
More quotes
Estimated financial data (e)
Sales 2022 29 546 M 3 020 M 3 020 M
Net income 2022 3 563 M 364 M 364 M
Net Debt 2022 2 216 M 226 M 226 M
P/E ratio 2022 21,4x
Yield 2022 1,63%
Sales 2023 31 413 M 3 210 M 3 210 M
Net income 2023 4 016 M 410 M 410 M
Net cash position 2023 573 M 58,5 M 58,5 M
P/E ratio 2023 18,9x
Yield 2023 1,85%
Capitalization 76 018 M 7 769 M 7 769 M
EV / Sales 2022 2,65x
EV / Sales 2023 2,40x
Nbr of Employees 10 892
Free-Float 79,8%
More Financials
Company
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination... 
More about the company
Ratings of Getinge AB
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about GETINGE AB
04/27Getinge To Buy France's FLUOPTICS in $27.4 Million Deal
MT
04/27GETINGE : to acquire FLUOPTICS, a technology leader in the area of Near Infrared Imaging
PU
04/27GETINGE AB : Ex-dividend day for final dividend
FA
04/26Resolutions at Getinge's Annual General Meeting 26 April 2022
AQ
04/26Getinge AB Declares Dividend for 2021, Payable on May 3, 2022
CI
04/26European stocks slide with eyes on U.S. tech earnings
RE
04/26TRANSCRIPT : Getinge AB, Q1 2022 Earnings Call, Apr 26, 2022
CI
04/26GETINGE : Presentation Q1 2022 Report
PU
04/26Medical gear maker Getinge's profit falls on supply chain trouble
RE
04/26Medical gear maker Getinge's profit falls on supply chain trouble
RE
04/26GETINGE INTERIM REPORT JANUARY-MARCH : Healthy order book but supply chain challenges
AQ
04/26Getinge AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/26GETINGE AB : 1st quarter report
CO
04/26GETINGE AB : Proxy Statments
CO
04/08GETINGE ANNOUNCES ITS Q1 REPORT 2022 : 00 CEST followed by a conference call at 10:00 CEST
AQ
More news
News in other languages on GETINGE AB
04/29PUMP / DUMP #57 : Les Tops & Flops de la semaine
04/27Getinge va racheter la société française FLUOPTICS pour 27,4 millions de dollars.
04/26MÄRKTE EUROPA/Erholung entpuppt sich als Bullenfalle
04/26POINT SUR LES FORTES VARIATIONS DU J : les suédoises prennent un coup de froid
04/26MÄRKTE EUROPA/Freundlich - aber unter Tageshoch
More news
Analyst Recommendations on GETINGE AB
More recommendations
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | GETI B | SE0000202624 | MarketScreener
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 279,10 SEK
Average target price 415,67 SEK
Spread / Average Target 48,9%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandstr÷m Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB-29.36%7 769
MASIMO CORPORATION-51.68%7 852
NOVOCURE LIMITED-1.98%7 696
SHOCKWAVE MEDICAL, INC.-9.89%5 751
PENUMBRA, INC.-51.26%5 277
ASAHI INTECC CO., LTD.-21.08%4 186